The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Minimally Invasive Treatment Of Lung Cancer Market In 2026 And What Value Is Projected For 2030?
The market for minimally invasive treatment of lung cancer has demonstrated robust expansion over recent years. This market is projected to expand from $3.35 billion in 2025 to $3.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. Historically, this expansion has been driven by factors such as a rise in lung cancer incidence rates, the proliferation of oncology treatment centers, advancements in interventional radiology techniques, increased accessibility to minimally invasive treatment methods, and the growing clinical adoption of ablation therapies.
The market size for the minimally invasive treatment of lung cancer is expected to demonstrate significant expansion over the next few years. It is projected to increase to $5.21 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.2%. This growth throughout the forecast period can be attributed to greater investments in precision cancer care, the rising adoption of robotic and AI-assisted oncology treatments, the expansion of early-stage lung cancer detection programs, an increasing demand for outpatient cancer procedures, and a heightened focus on personalized treatment pathways. Prominent trends for the forecast period include the increasing adoption of image-guided tumor ablation techniques, a rising utilization of minimally invasive embolization procedures, the growing integration of robotic assistance in oncology care, the expansion of precision oncology treatment platforms, and an enhanced focus on reducing treatment-related complications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Minimally Invasive Treatment Of Lung Cancer Market?
The growing occurrence of lung cancer is anticipated to stimulate the expansion of the minimally invasive treatment of lung cancer market in the coming period. This condition is a malignancy starting in the lungs, marked by unregulated cellular proliferation. Its rise is primarily attributed to heightened tobacco smoking, which boosts the probability of rampant cell division and tumor development. Minimally invasive approaches benefit lung cancer sufferers by precisely targeting, excising, or eliminating tumors via small cuts or probes guided by imaging, thereby shortening recuperation periods, lessening harm to healthy lung tissue, decreasing complication risks, and enabling a quicker return to routine activities. As an illustration, in January 2023, the American Cancer Society, a U.S.-based non-profit organization, reported that in 2023, around 238,340 people, consisting of 117,550 men and 120,790 women, are projected to receive a lung cancer diagnosis, with an estimated 127,070 fatalities from the illness. Consequently, the expanding occurrence of lung cancer is propelling the demand for the minimally invasive treatment of lung cancer market.
What Are The Key Segments Of The Minimally Invasive Treatment Of Lung Cancer Market?
The minimally invasive treatment of lung cancer market covered in this report is segmented –
1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions
Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization
What Trends Are Affecting The Expansion Of The Minimally Invasive Treatment Of Lung Cancer Market?
Major companies active in the minimally invasive treatment of lung cancer market are concentrating on developing advanced solutions, such as microwave ablation systems and navigation-assisted biopsy platforms, to address the increasing demand for lung-sparing therapies, quicker diagnoses, shorter hospital stays, and treatment options for individuals unsuitable for open surgery. Microwave ablation (MWA) devices transmit high-frequency electromagnetic energy through a probe to rapidly heat and coagulate tumour tissue, resulting in predictable spherical ablation zones with faster treatment durations and reduced heat-sink effect compared to radiofrequency ablation. For instance, in January 2025, Creo Medical Group plc, a UK-based medical device company specialising in minimally invasive surgical endoscopy, introduced the MicroBlate Flex soft-tissue microwave ablation system and moved it into clinical study for lung lesions. The MicroBlate Flex system is composed of a microwave generator and a flexible ablation applicator, designed for use across various soft-tissue indications. It operates by emitting high-frequency microwave energy at the applicator tip to create controlled thermal zones that eradicate tumour cells. The system’s distinctive features include a high-frequency power profile for efficient energy deposition, a flexible delivery design intended to access difficult anatomies, and compatibility with endoscopic or percutaneous approaches, enabling applications in small pulmonary nodules, metastatic lung lesions, and patients who cannot tolerate lobectomy. Clinically, this leads to shorter procedure times, a decreased need for general anaesthesia, potential outpatient workflows, and an expanded set of treatment options when compared with open surgery or stereotactic radiotherapy.
Who Are The Leading Companies Operating In The Minimally Invasive Treatment Of Lung Cancer Market?
Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH, Cook Medical Incorporated, Terumo Corporation, Merit Medical Systems Inc., Sirtex Medical Limited
Read the full minimally invasive treatment of lung cancer market report here:
What Are The Leading Geographic Regions In The Minimally Invasive Treatment Of Lung Cancer Market?
North America was the largest region in the minimally invasive treatment of lung cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Minimally Invasive Treatment Of Lung Cancer Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp
Browse Through More Reports Similar to the Global Minimally Invasive Treatment Of Lung Cancer Market 2026, By The Business Research Company
Hydrofluoric Acid Global Market Report
https://www.thebusinessresearchcompany.com/report/hydrofluoric-acid-global-market-report
Electronic Grade Hydrofluoric Acid Global Market Report
Fluoropolymer Films Global Market Report
https://www.thebusinessresearchcompany.com/report/fluoropolymer-films-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model